Synapse

← ISRN Oncology

Papers in ISRN Oncology

Page 3 · newest first

  1. The Distribution of PSA Age-Specific Profiles in Healthy Irish Men between 20 and 70ISRN Oncology · 2012
  2. Microsatellite Instability in Sarcoma: Fact or Fiction?ISRN Oncology · 2012
  3. Comparison of Gene Expression Profiling in Sarcomas and Mesenchymal Stem Cells Identifies Tumorigenic Pathways in Chemically Induced Rat Sarcoma ModelISRN Oncology · 2012
  4. Prognostic Factors and Recurrence in Breast Cancer: Experience at the National Cancer Institute of MexicoISRN Oncology · 2012
  5. Treatment Options for Metaplastic Breast CancerISRN Oncology · 2012
  6. Biologic Therapy in Head and Neck Cancer: A Road with HurdlesISRN Oncology · 2012
  7. Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate CancerISRN Oncology · 2012
  8. Proof of Concept to Clinical Confirmation: Evolving Clinical Trial Designs for Targeted AgentsISRN Oncology · 2012
  9. H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic CancerISRN Oncology · 2012
  10. The Role of Somatostatin Receptor Scintigraphy on the Diagnosis of Desmoid TumorsISRN Oncology · 2012
  11. Phase 1 Clinical Trial of Trametes versicolor in Women with Breast CancerISRN Oncology · 2012
  12. Upregulation of TLR1, TLR2, TLR4, and IRAK-2 Expression During ML-1 Cell Differentiation to Macrophages: Role in the Potentiation of Cellular Responses to LPS and LTAISRN Oncology · 2012
  13. Epidemiological Characteristics and Survival Studies of Rhabdomyosarcoma in East Egypt: A Five-Year Multicenter StudyISRN Oncology · 2012
  14. Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical TrialISRN Oncology · 2012
  15. Hepatocellular Carcinoma: Focus on Different Aspects of ManagementISRN Oncology · 2012
  16. Metastatic Squamous Cell Carcinoma of the Anus: Time for a Shift in the Treatment Paradigm?ISRN Oncology · 2012
  17. The Role of Transoral Robotic Surgery in the Management of Oropharyngeal Cancer: A Review of the LiteratureISRN Oncology · 2012
  18. Parameters of Blood Count and Tumor Markers in Patients with Borderline Ovarian Tumors: A Retrospective Analysis and Relation to StagingISRN Oncology · 2012
  19. Activating Death Receptor DR5 as a Therapeutic Strategy for RhabdomyosarcomaISRN Oncology · 2012
  20. Mucosal Melanomas of the Head and Neck: The Role of Postoperative Radiation TherapyISRN Oncology · 2012
  21. Epithelial Mesenchymal Transition: A New Insight into the Detection of Circulating Tumor CellsISRN Oncology · 2012
  22. Sex Variability in Pediatric Leukemia Survival: Large Cohort EvidenceISRN Oncology · 2012
  23. Epithelial-Mesenchymal Transition in Oral Squamous Cell CarcinomaISRN Oncology · 2012
  24. Time-Dependent Changes of Plasma Concentrations of Angiopoietins, Vascular Endothelial Growth Factor, and Soluble Forms of Their Receptors in Nonsmall Cell Lung Cancer Patients Following Surgical ResectionISRN Oncology · 2012
  25. The Impact of ¹⁸F-FDG PET CT Prior to Chemoradiotherapy for Stage III/IV Head and Neck Squamous Cell CarcinomaISRN Oncology · 2012
  26. Optical Detection of Preneoplastic Lesions of the Central AirwaysISRN Oncology · 2012
  27. Brain Metastases from Endometrial CarcinomaISRN Oncology · 2012
  28. Pathological Fracture of the Proximal Femur in Osteosarcoma: Need for Early Radical Surgery?ISRN Oncology · 2012
  29. Comparison of Whole Genome Amplification Methods for Analysis of DNA Extracted from Microdissected Early Breast Lesions in Formalin-Fixed Paraffin-Embedded TissueISRN Oncology · 2012
  30. Epithelial Cell Dissemination and Readhesion: Analysis of Factors Contributing to Metastasis Formation in Breast CancerISRN Oncology · 2012
  31. Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced DiseaseISRN Oncology · 2012
  32. Comparing Lung Cancer Risks in Sweden, USA, and JapanISRN Oncology · 2012
  33. Pediatric Thyroid Carcinoma Incidence and Temporal Trends in the USA (1973–2007): Race or Shifting Diagnostic Paradigm?ISRN Oncology · 2012
  34. Toll-Like Receptors as Novel Therapeutic Targets for Ovarian CancerISRN Oncology · 2012
  35. Integrin Signaling in Mammary Epithelial Cells and Breast CancerISRN Oncology · 2012
  36. Prognostic Biomarkers and EBV Infection Research in Diffuse Large B-Cell Lymphoma of the Palatine TonsilsISRN Oncology · 2012
  37. High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic VariablesISRN Oncology · 2012
  38. Nutrition Support for Head and Neck Squamous Cell Carcinoma Patients Treated with Chemoradiotherapy: How Often and How Long?ISRN Oncology · 2012
  39. In Silico Experimental Modeling of Cancer TreatmentISRN Oncology · 2012
  40. High-Grade Prostate Cancer: Favorable Results in the Modern Era Regardless of Initial TreatmentISRN Oncology · 2012
  41. Relationship between Latitude and Melanoma in ItalyISRN Oncology · 2012
  42. No Prognostic Impact of p53 and P-Glycoprotein Expression in Patients with Diffuse Large B-Cell LymphomaISRN Oncology · 2011
  43. Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A ReviewISRN Oncology · 2011
  44. Papillary Thyroid Carcinoma: Differential Diagnosis and Prognostic Values of Its Different Variants: Review of the LiteratureISRN Oncology · 2011
  45. An Evaluation of the Spontaneous Proliferation of Peripheral Blood Mononuclear Cells in HTLV-1-Infected Individuals Using Flow CytometryISRN Oncology · 2011
  46. Tumor Vascular Morphology Undergoes Dramatic Changes during Outgrowth of B16 Melanoma While Proangiogenic Gene Expression Remains UnchangedISRN Oncology · 2011
  47. Brain Metastases from Ovarian CarcinomaISRN Oncology · 2011
  48. Androgen Receptor in Laryngeal Carcinoma: Could There Be an Androgen-Refractory Tumor?ISRN Oncology · 2011
  49. Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1–3 Axillary Lymph Node(s) MetastasisISRN Oncology · 2011
  50. High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour PatientsISRN Oncology · 2011